-
1دورية أكاديمية
المؤلفون: Heukers, R, Fan, TS, de Wit, RH, van Senten, JR, De Groof, TWM, Bebelman, MP, Lagerweij, T, Vieira, J, de Munnik, SM, Smits-de Vries, L, van Offenbeek, J, Rahbar, A, van Hoorick, D, Soderberg-Naucler, C, Wurdinger, T, Leurs, R, Siderius, M, Vischer, HF, Smit, MJ
المصدر: Oncogene. 37(30):4110-4121
مصطلحات موضوعية: Medicin och hälsovetenskap
-
2دورية أكاديمية
المؤلفون: Lollinga, WT, de Wit, RH, Rahbar, A, Vasse, GF, Davoudi, B, Diepstra, A, Riezebos-Brilman, A, Harmsen, MC, Hillebrands, JL, Soderberg-Naucler, C, van Son, WJ, Smit, MJ, Sanders, JS, van den Born, J
المصدر: Transplantation. 101(3):531-540
مصطلحات موضوعية: Medicin och hälsovetenskap
-
3مؤتمر
المؤلفون: Lollinga, W, Rahbar, A, De Wit, RH, Riezebos-Brilman, A, Soderberg-Naucler, C, Van Son, WJ, Sanders, JS, Smit, MJ, Van den Born, J
المصدر: NEPHROLOGY DIALYSIS TRANSPLANTATION. 29:452-453
مصطلحات موضوعية: Medicin och hälsovetenskap
-
4دورية أكاديمية
المؤلفون: de Wit RH; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Heukers R; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Brink HJ; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Arsova A; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Maussang D; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Cutolo P; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Strubbe B; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Vischer HF; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Bachelerie F; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.)., Smit MJ; Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.H.d.W., R.H., H.J.B., A.A., D.M., H.F.V, M.J.S.); Inflammation Chemokines and Immunopathology, INSERM, Faculté de Médicine-Université Paris-Sud, Université Paris-Saclay, Clamart, France (P.C., F.B.); and Ablynx N.V., Zwijnaarde, Belgrium (B.S.) mj.smit@vu.nl.
المصدر: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2017 Oct; Vol. 363 (1), pp. 35-44. Date of Electronic Publication: 2017 Aug 02.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
مواضيع طبية MeSH: Antibody Specificity*, Immunologic Deficiency Syndromes/*immunology , Immunologic Deficiency Syndromes/*therapy , Receptors, CXCR4/*immunology , Single-Chain Antibodies/*immunology , Single-Chain Antibodies/*therapeutic use , Warts/*immunology , Warts/*therapy, HEK293 Cells ; Humans ; Immunologic Deficiency Syndromes/genetics ; Mutation ; Primary Immunodeficiency Diseases ; Receptors, CXCR4/genetics ; Warts/genetics
SCR Disease Name: WHIM syndrome
-
5دورية أكاديمية
المؤلفون: de Wit RH; Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, De Boelelaan, Amsterdam, The Netherlands., Mujić-Delić A; Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, De Boelelaan, Amsterdam, The Netherlands., van Senten JR; Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, De Boelelaan, Amsterdam, The Netherlands., Fraile-Ramos A; Division of Cell Biology, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Siderius M; Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, De Boelelaan, Amsterdam, The Netherlands., Smit MJ; Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, De Boelelaan, Amsterdam, The Netherlands.
المصدر: Oncotarget [Oncotarget] 2016 Oct 18; Vol. 7 (42), pp. 67966-67985.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
مواضيع طبية MeSH: Signal Transduction*, Carrier Proteins/*metabolism , Glioblastoma/*metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism , Membrane Proteins/*metabolism , Receptors, Chemokine/*metabolism , Thyroid Hormones/*metabolism , Viral Proteins/*metabolism, Animals ; Carrier Proteins/genetics ; Cell Line, Tumor ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/metabolism ; Cells, Cultured ; Cytomegalovirus/physiology ; Fibroblasts/metabolism ; Fibroblasts/virology ; Glioblastoma/genetics ; Glioblastoma/virology ; HEK293 Cells ; Host-Pathogen Interactions ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/genetics ; Male ; Membrane Proteins/genetics ; Mice ; NIH 3T3 Cells ; Receptors, Chemokine/genetics ; Thyroid Hormones/genetics ; Viral Proteins/genetics ; Thyroid Hormone-Binding Proteins
-
6دورية أكاديمية
المؤلفون: de Wit RH; Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Vrije Universiteit, Amsterdam, The Netherlands., de Munnik SM; Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Vrije Universiteit, Amsterdam, The Netherlands., Leurs R; Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Vrije Universiteit, Amsterdam, The Netherlands., Vischer HF; Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Vrije Universiteit, Amsterdam, The Netherlands., Smit MJ; Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Vrije Universiteit, Amsterdam, The Netherlands. Electronic address: mj.smit@vu.nl.
المصدر: Methods in enzymology [Methods Enzymol] 2016; Vol. 570, pp. 457-515. Date of Electronic Publication: 2016 Jan 19.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0212271 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7988 (Electronic) Linking ISSN: 00766879 NLM ISO Abbreviation: Methods Enzymol Subsets: MEDLINE
مواضيع طبية MeSH: Chemokines/*metabolism , Molecular Biology/*methods , Molecular Targeted Therapy/*methods , Receptors, Chemokine/*metabolism, Allosteric Regulation ; Animals ; Binding, Competitive ; Cell Line ; Chemotaxis ; Guanosine 5'-O-(3-Thiotriphosphate)/metabolism ; Humans ; Iodine Radioisotopes ; Ligands ; Protein Binding ; Receptors, Chemokine/agonists ; Receptors, Chemokine/antagonists & inhibitors ; Signal Transduction/drug effects ; beta-Arrestins/metabolism
-
7دورية أكاديمية
المؤلفون: Mujić-Delić A; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, de Boelelaan 1083, 1081 HV Amsterdam, The Netherlands., de Wit RH; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, de Boelelaan 1083, 1081 HV Amsterdam, The Netherlands., Verkaar F; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, de Boelelaan 1083, 1081 HV Amsterdam, The Netherlands., Smit MJ; Amsterdam Institute for Molecules, Medicines and Systems (AIMMS), Division of Medicinal Chemistry, Faculty of Sciences, VU University Amsterdam, de Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. Electronic address: mj.smit@vu.nl.
المصدر: Trends in pharmacological sciences [Trends Pharmacol Sci] 2014 May; Vol. 35 (5), pp. 247-55. Date of Electronic Publication: 2014 Mar 30.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Published By Elsevier In Association With The International Union Of Pharmacology Country of Publication: England NLM ID: 7906158 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3735 (Electronic) Linking ISSN: 01656147 NLM ISO Abbreviation: Trends Pharmacol Sci Subsets: MEDLINE
-
8دورية أكاديمية
المؤلفون: Krekel NM; Department of Surgical Oncology, VU University Medical Center, Amsterdam, Netherlands., Haloua MH, Lopes Cardozo AM, de Wit RH, Bosch AM, de Widt-Levert LM, Muller S, van der Veen H, Bergers E, de Lange de Klerk ES, Meijer S, van den Tol MP
المصدر: The Lancet. Oncology [Lancet Oncol] 2013 Jan; Vol. 14 (1), pp. 48-54. Date of Electronic Publication: 2012 Dec 04.
نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Ultrasonography, Mammary*, Breast Neoplasms/*surgery , Mastectomy, Segmental/*methods, Adult ; Aged ; Breast Neoplasms/pathology ; Female ; Humans ; Intraoperative Period ; Middle Aged ; Neoplasm Staging ; Palpation ; Treatment Outcome
-
9دورية أكاديمية
المصدر: Biochimica et biophysica acta [Biochim Biophys Acta] 1985 Mar 20; Vol. 824 (3), pp. 256-61.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Elsevier Pub. Co Country of Publication: Netherlands NLM ID: 0217513 Publication Model: Print Cited Medium: Print ISSN: 0006-3002 (Print) Linking ISSN: 00063002 NLM ISO Abbreviation: Biochim Biophys Acta Subsets: MEDLINE
مواضيع طبية MeSH: Protein Biosynthesis*, Carbon Tetrachloride Poisoning/*metabolism , Mitochondria, Liver/*metabolism, Animals ; Chloramphenicol/pharmacology ; Electrophoresis, Polyacrylamide Gel ; Fluorometry ; Male ; Methionine/metabolism ; Rats ; Rats, Inbred Strains ; Time Factors